MLH1 and cancer: We first examined in CTX‐treated training cohort (N = 102, with 40 months follow up) of MLH1 protein expression by immunohistochemistry (IHC) MLH1 protein was mainly located in the nucleus of cancer cells (Figure 1A) and its reduction was found to be associated with poor prognosis.